If it's not right for you, you'll hear that from us
Well, I will so I will share for listeners
TMAO is a Possible Factor in Clopidogrel Resistance Clopidogrel selectively inhibits the binding of ADP to the P2Y12 receptor on the platelet surface and the ADP-mediated activation of the glycoprotein GPIIb/IIIa complex, thereby constraining platelet aggregation
Regular monitoring ensures both medications contribute positively to your health outcomes without unnecessary adverse effects
Herzenberg LA, De Rosa SC, Dubs JG, Roederer M, Anderson MT, Ela SW, Deresinski SC, Herzenberg LA
It is closely connected to health problems like obesity, insulin resistance, type 2 diabetes, and high cholesterol